Alzheimer
Alzheimer’s Dementia: Genetics play a role!

Alzheimer’s Dementia: Genetics play a role!

H2 Global Group holds an international patent for the treatment and mitigation of Alzheimer’s disease. It combines a proprietary inhalation device, hydrogen water and dietary supplements. The company is now linking its discovery to personalized healthcare. Scientists warn – the number of sufferers is rising steeply and close relatives are at up to 4 times the risk!

Read more
Molecular hydrogen: New hope for Alzheimer’s patients

Molecular hydrogen: New hope for Alzheimer’s patients

H2 Global Group has been granted a patent for a promising method of treating Alzheimer’s disease using molecular hydrogen. This innovative approach reduces oxidative stress, a key factor in the pathogenesis of Alzheimer’s disease (AD), and offers long-term improvements in cognitive function and overall quality of life for patients.

Read more
H2 Global Group
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.